Headache impact of chronic and episodic migraine: results in a series of 1113 patients

被引：0
|
作者：
Mulero, P. [1 ]
Guerrero, A. L. [1 ]
Pedraza, M. [1 ]
Sanchez, A. [1 ]
Sierra, L. [1 ]
Herrero, S. [1 ]
Ayllon, B. [1 ]
Gomez, A. B. [1 ]
Garcia, A. [1 ]
Baron, J. [1 ]
Munoz, I. [1 ]
Fernandez, R. [1 ]
机构：
[1] Univ Hosp, Valladolid, Spain
来源：
JOURNAL OF NEUROLOGY | 2012年 / 259卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S161 / S161
页数：1
相关论文
共 50 条
  • [21] Reduction in the Number of Headache Hours in Chronic and Episodic Migraine With Fremanezumab
    Cohen, Joshua
    Gandhi, Sanjay
    Yang, Ronghua
    NEUROLOGY, 2019, 92 (15)
  • [22] Medical Consultation and Headache-Impact among Persons with Chronic Migraine (CM) and Episodic Migraine (EM): Results from the American Migraine Prevalence and Prevention (AMPP) Study
    Manack, Aubrey N.
    Buse, Dawn C.
    Serrano, Daniel
    Varon, Sepideh F.
    Turkel, Catherine C.
    Lipton, Richard B.
    ANNALS OF NEUROLOGY, 2011, 70 : S62 - S63
  • [23] Medical Consultation and Headache-Impact among Persons with Chronic Migraine (CM) and Episodic Migraine (EM): Results from the American Migraine Prevalence and Prevention (AMPP) Study
    Manack, A. N.
    Buse, D. C.
    Serrano, D.
    Reed, M. L.
    Turkel, C. C.
    Lipton, R. B.
    HEADACHE, 2011, 51 : 33 - 33
  • [24] Reduction in the severity and duration of headache following fremanezumab treatment in patients with episodic and chronic migraine
    Ashina, Messoud
    Cohen, Joshua M.
    Gandhi, Sanjay K.
    Du, Evelyn
    HEADACHE, 2021, 61 (06): : 916 - 926
  • [25] REDUCTION IN THE NUMBER OF HEADACHE HOURS IN CHRONIC AND EPISODIC MIGRAINE WITH FREMANEZUMAB
    Cohen, J. M.
    Gandhi, S. K.
    Yang, R.
    CEPHALALGIA, 2018, 38 : 62 - 62
  • [26] Incidence and predictors for chronicity of headache in patients with episodic migraine
    Katsarava, Z
    Schneeweiss, S
    Kurth, T
    Kroener, U
    Fritsche, G
    Eikermann, A
    Diener, HC
    Limmroth, V
    NEUROLOGY, 2004, 62 (05) : 788 - 790
  • [27] Real-world Reductions in Migraine and Headache Days for Patients With Chronic and Episodic Migraine Initiating Fremanezumab in the US
    Cohen, Joshua M.
    Thompson, Stephen
    Patterson-Lomba, Oscar
    Driessen, Maurice
    Seminerio, Michael
    Carr, Karen
    Mu, Fan
    NEUROLOGY, 2021, 96 (15)
  • [28] Effect of Galcanezumab on Severity of Headache and Associated Symptoms of Migraine in Phase 3 Trials in Patients with Episodic or Chronic Migraine
    Day, Kathleen A.
    Ament, Michael
    Stauffer, Virginia L.
    Skljarevski, Vladimir
    Rettiganti, Mallikarjuna
    Pearlman, Eric M.
    Aurora, Sheena K.
    NEUROLOGY, 2019, 92 (15)
  • [29] The Impact of Migraine on Physical Functioning in Adults with Chronic and Episodic Migraine
    Kawata, A. K.
    Hareendran, A.
    Shaffer, S.
    Mannix, S.
    Sapra, S.
    Desai, P.
    Ortmeier, B. G.
    Lipton, R. B.
    Dodick, D. W.
    Stewart, W. F.
    HEADACHE, 2017, 57 : 162 - +
  • [30] Update on guideline for migraine prophylaxis for episodic and chronic migraine from the Canadian Headache Society
    Medrea, Ioana
    Christie, Suzanne
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
12345